Colorectal Cancer

Central obesity measures of waist circumference and waist-to-hip ratio appear to be more accurate and consistent indicators of colorectal cancer incidence compared with BMI, according to a study published in JAMA Network Open.

Oral anticoagulant or antiplatelet medication use had no substantial effect on the accuracy of multitarget stool DNA testing for colorectal cancer, according to a study published in Gastro Hep Advances.

People with first-degree relatives who were repeatedly diagnosed with colorectal polyps appeared at increased risk for colorectal cancer, especially early-onset CRC, according to a study published in Gastroenterology.

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K pathway, according to results of the randomized ALASCCA study presented at ASCO Gastrointestinal Cancers Symposium.

An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a large prospective trial presented at ASCO Gastrointestinal Cancers Symposium.

Increased intake of calcium and dairy reduced the risk for colorectal cancer, a prospective cohort analysis published in Nature Communications revealed.

Cost-effectiveness and optimal stopping ages for colorectal cancer screening after age 75 years appear to be associated with an individual’s age, sex, comorbidity status and screening history, according to results of an economic evaluation.

The FDA approved two oncology regimens on Jan. 16.

Cancer incidence has continued to rise in the U.S. since the 1990s — particularly among women and younger adults, according to an American Cancer Society report.

Individuals with negative colonoscopy screening results had lower long-term risk for colorectal cancer and related mortality, with researchers suggesting the recommended 10-year rescreening interval may be extended for this population.